Preventing Clostridium Difficile Infection in the Intensive Care Unit - 24/11/12
, Andrew F. Shorr, MD, MPH c, d
Corresponding author. EviMed Research Group, LLC, PO Box 303, Goshen, MA 01032.Résumé |
Clostridium difficile is a formidable problem in the twenty-first century. Because of injudicious use of antibiotics, the emergence of the hypervirulent epidemic strain of this organism has been difficult to contain. The NAP1/BI/027 strain causes more-severe disease than other widely prevalent strains and affects patients who were not traditionally thought to be at risk for Clostridium difficile infection. Critically ill patients remain at high risk for this pathogen, and preventive measures, such as meticulous contact precautions, hand hygiene, environmental disinfection, and, most importantly, antibiotic stewardship, are the cornerstones of mitigation in the intensive care unit.
Le texte complet de cet article est disponible en PDF.Keywords : Clostridium difficile, Infectious diarrhea, ICU, Antibiotic stewardship
Plan
| Disclosure: Dr Zilberberg has received consulting fees and research funding from ViroPharma, manufacturer of Vancocin; and Optimer, manufacturer of fidoxamicin. The content of this manuscript was presented in part at the Society of Critical Care Medicine 2012 annual meeting. |
Vol 29 - N° 1
P. 11-18 - janvier 2013 Retour au numéro
Article précédent
- Achieving Zero Central Line–associated Bloodstream Infection Rates in Your Intensive Care Unit
- Rommel Sagana, Robert C. Hyzy
- Preventing Catheter-Associated Urinary Tract Infections in the Intensive Care Unit
- Carol Chenoweth, Sanjay Saint
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?